CATUG is proud to announce our participation in the Asia Summit on Global Health (ASGH) 2026. As a member of the Hong Kong Science and Technology Parks (HKSTP), CATUG leverages the strategic advantages of the Greater Bay Area to connect global nucleic acid innovation with industrial excellence.

Join us in Hong Kong to explore the future of advanced therapies and collaborative opportunities.

Keynote Presentation

• Topic: Accelerating Advanced Therapy Pipelines: From Discovery to Clinical Proof-of-Concept and Beyond
•  
• Speaker: Dr. Yixiong Chen, Global Business Director at CATUG
•  
• Time: May 12, 14:30

Highlights:

• End-to-End CRDMO Platform: Insights into CATUG’s integrated services covering plasmid construction, IVT, xRNA-LNP delivery systems, and drug product manufacturing.
•  
• Frontier Applications: How our expertise in gene editing, in vivo CAR-T, and protein replacement accelerates pipelines from the lab to industrialization.
•  
• GBA Synergy: Leveraging the Greater Bay Area’s supply chain and Hong Kong’s status as a global hub to support cross-border development and international clinical entry.

Visit Our Booth

Connect with our experts face-to-face to discuss customized technical solutions and project landing support.

• Booth Number: 3F-A11
•  
• Date: May 11–12, 2026
•  
• Location: Hall 3F/G, Hong Kong Convention and Exhibition Centre (HKCEC)

About ASGH

The Asia Summit on Global Health (ASGH) is Asia’s premier event for health innovation and investment. Jointly organized by the Government of the HKSAR and the Hong Kong Trade Development Council (HKTDC), it serves as a one-stop platform for policymakers, healthcare experts, and business leaders to foster collaboration in the dynamic healthcare sector.

Book a Meeting: Interested in a 1-on-1 consultation? Please visit our LinkedIn page www.linkedin.com/company/catug to schedule a session and discover how CATUG can empower your next breakthrough.